X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Ipca Laboratories Ltd.
BSE CODE: 524494   |   NSE CODE: IPCALAB   |   ISIN CODE : INE571A01038   |   15-May-2026 Hrs IST
BSE NSE
Rs. 1605.75
23.1 ( 1.46% )
 
Prev Close ( Rs.)
1582.65
Open ( Rs.)
1603.35
 
High ( Rs.)
1654.00
Low ( Rs.)
1584.80
 
Volume
116980
Week Avg.Volume
39290
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1605.00
21.1 ( 1.33% )
 
Prev Close ( Rs.)
1583.90
Open ( Rs.)
1592.70
 
High ( Rs.)
1654.70
Low ( Rs.)
1584.80
 
Volume
1114457
Week Avg.Volume
532944
 
52 WK High-Low Range(Rs.)
1251.6
1654.7
Source DateBoard Meeting DateDetails
04-May-2026 29-May-2026 Audited Results & Dividend
22-Jan-2026 13-Feb-2026 Quarterly Results
17-Oct-2025 13-Nov-2025 Quarterly Results
24-Jul-2025 11-Aug-2025 Quarterly Results
14-May-2025 29-May-2025 Audited Results & Final Dividend
27-Jan-2025 13-Feb-2025 Quarterly Results
24-Oct-2024 14-Nov-2024 Quarterly Results & Interim Dividend
23-Sep-2024 30-Sep-2024 Inter alia, to consider and approve:- (1) Integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (wholly owned subsidiary of Company?s subsidiary)
24-Jul-2024 13-Aug-2024 Quarterly Results
07-May-2024 29-May-2024 Final Dividend & Audited Results
Page 1 of 11
PREV || NEXT